Archean Chemical Industries Ltd

Q3 FY25Chemicals & Petrochemicals

Archean Chemical Industries Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹498

Market cap₹6.5K Cr

P/E66.8

Updated23 Aug 2026

Read4 min read

The short version

June 2024 quarter marked the lowest sales in 2-3 years; improvement expected going forward with new units addition. Company anticipates a recovery and gradual pickup in demand for bromine and salt businesses starting FY ’26.

From Archean Chemical Industries Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

June 2024 quarter marked the lowest sales in 2-3 years; improvement expected going forward with new units addition.
Anticipated volume pickup over recent months in bromine and salt, with continual efforts to increase volumes.
FY 2026 likely to see double-digit revenue growth due to base business recovery and derivative business ramp-up.
Bromine production targeted at 20,000 to 25,000 metric tons in FY 2026, including captive consumption.
Bromine derivatives business (Acume) expected to contribute significantly in FY 26, with clear brine fluids and PTA synthesis ramping up.
Salt business recovering post-monsoon and cyclone disruptions; aiming for 1 million to 1.2 million tons run-rate soon.

2 more points management made on revenue & sales performance

Profitability & Margins

Company anticipates a recovery and gradual pickup in demand for bromine and salt businesses starting FY ’26.
Bromine production target for FY ’26 is 20,000 to 25,000 metric tons including captive consumption, signaling potential volume growth.
Bromine derivative business (clear brine fluids and PTA synthesis) expected to ramp up, contributing to meaningful revenue growth in FY ’26.
Salt volumes are set for improvement post logistics disruptions, aiming for a 1 to 1.2 million tons run rate in coming quarters.
Revenue growth for FY ‘26 is expected to be in double digits, driven by base business growth and derivatives ramp-up.
Operational profits and EBITDA margins improved in Q3 FY ’25; continued focus on cost optimization and supply chain efficiency.

2 more points management made on profitability & margins

See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Semiconductor Facility: Through subsidiary SiCSem Private Limited, an investment of about Rs. 3,000 crores is planned for a compound semiconductor fab in Odisha, targeting industries like electric vehicles, energy storage, and data centers. Land allotment and groundbreaking are done; next steps include permissions and construction over 24-30 months post-shovel down (post-Jan 2025).
Clas-SiC Investment: Strategic investment in UK-based Clas-SiC Wafer Fab Limited to acquire process know-how and technology for silicon carbide wafers. Initial subscriptions of GBP 10 million plus GBP 2.5 million secondary purchase completed; balance pending.
Offgrid Energy Labs: Committed $12 million investment in a US company specializing in zinc bromide battery technology, complementary to bromine business and focused on energy storage solutions. Pilot plant to be set up in the UK with plans for an India factory later.
Near-Term Capex: Limited to ground work, civil and equipment advances for semiconductor and Offgrid projects; no major CAPEX beyond these in the next 6-12 months.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential

1Shiv Texchem Ltd₹265 Cr

Rev 1Mar 2

2Solar Industries₹1.8L Cr

Rev 2Mar 1

3₹1.7K Cr

Rev 2Mar 1

4₹4.8K Cr

Rev 2Mar 3

5₹3.7K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The Company remains net debt free and has a strong balance sheet, focusing on using the balance sheet prudently without unnecessary exposure at the parent level.
For the large Rs. 3,000 crores investment in the semiconductor facility through subsidiary SiCSem Private Limited, financing mix details will be clearer after financial closure; a good part of CAPEX is expected to be subsidized by the Odisha state government.
The Company will likely need to approach the banking system for financing this large project, but they remain sensitive to leverage.

2 more points management made on fundraising & capital structure

See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The Company’s order book continues to be healthy as of Q3 FY ’25.
Both bromine and salt volumes have been locked in for the next six to twelve months.
Despite short-term moderation in demand, the Company believes these are temporary.
New clients have been onboarded recently, indicating strong future growth and buyer confidence.
The company notes that the market is healthy with continued offtake for bromine products.

2 more points management made on order book & pipeline

Archean Chemical Industries Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Archean Chemical's management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Archean Chemical Industries Ltd Q3 FY25 results?

What is Archean Chemical Industries Ltd share price analysis?

Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.

Is Archean Chemical Industries Ltd planning capital expenditure?

Semiconductor Facility: Through subsidiary SiCSem Private Limited, an investment of about Rs.

Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.